Business Wire

CA-ZYNGA

Share
Zynga Teams up with Girls Who Code to Help Raise Awareness and Support for Women in Tech

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced that it has teamed up with Girls Who Code in support of International Women’s Day 2021. With a mission to raise awareness and support for women in tech, Zynga has pledged $100,000 from its Social Impact Fund to enable Girls Who Code (GWC) to support girls at all points throughout their educational journey from 3rd grade into the workforce.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210308005082/en/

GWC is an international non-profit organization dedicated to closing the gender gap in technology. The organization has reached more than 300,000 girls in the US, Canada, UK, and India; 50 percent of girls served are Black, Latinx, or from low-income backgrounds. Through its free Clubs program, GWC reaches young women at the most critical point in the pipeline, equipping them to use Computer Science to impact their community and providing a sisterhood of supportive peers and mentors to help them persist and succeed.

“Zynga is honored to team up with Girls Who Code to help forge a more inclusive industry in tech and games by expanding opportunities for girls and women across the globe,” said Phuong Phillips, Chief Legal Officer at Zynga. “Through their virtual workshops, school clubs, mentorship programs, networking and more, we are hoping to build the next generation of women in STEAM to help them to prepare and thrive in the tech workforce. With an incredible group of women at Zynga already doing so much to support our studios and employees around the world, it’s important that we take positive steps to help strengthen the future of our industry for years to come.”

“We know that passionate, diverse, ambitious young women are the key to transforming our workplace and our world,” said Dr. Tarika Barrett, incoming CEO at Girls Who Code. “We’re excited to partner with Zynga this International Women’s Day to send a loud signal to young women everywhere that they belong in technology and that they have support in their journey from school into the workforce. Zynga and Girls Who Code share a vision of a more fair and equitable workforce, where women of all backgrounds rise to the top.”

GWC now has more than 80,000 college-aged alumni, who are majoring in Computer Science and related fields at 15 times the U.S. average. At its current pace, the organization is on track to close the gender gap in new entry-level Computer Science and related jobs by 2030. With Zynga’s support, GWC will continue to expand its free Clubs and alumni programming, helping young women unlock opportunities in the technical workforce and connecting young women to role models and mentors to support them on their journey in tech.

This March, Zynga’s social channels will be shining a spotlight on some of the incredible women who help to promote a more inclusive workplace for Zynga’s family of studios around the world. Furthermore Small Giant Games , a subsidiary of Zynga Inc., will be calling on its global network of players in Empires & Puzzles to help raise awareness by changing their alliance description to include the hashtag #ChooseToChallenge - the theme for this year’s International Women’s Day. From now until March 14, a raised hand emoji has been included exclusively for the in-game chat function and, additionally, a raised hand avatar pin will also be rewarded to players who participate in this event.

For more information please visit:
www.zynga.com
www.girlswhocode.com
www.internationalwomensday.com

Editor’s notes
Key art and assets available for use at the following link:
https://www.dropbox.com/sh/x7ey7f7kht5zbym/AADtJroaLak7G56DjgAbIVBra?dl=0

Empires & Puzzles is available to download for free on iOS and Android .

About Zynga
Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing™ , Empires & Puzzles™ , Merge Dragons!™ , Merge Magic!™ , Toon Blast™ , Toy Blast™ , Words With Friends™ and Zynga Poker™ . Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, the U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter , Instagram , Facebook or the Zynga blog .

About Girls Who Code
Girls Who Code is an international non-profit organisation working to close the gender gap in technology and change the image of what a programmer looks like and does. With their programs, they are leading the movement to inspire, educate, and equip young women with the computing skills to pursue 21st-century opportunities. Girls Who Code has reached 300,000 girls to date through its programs and 500 million people through campaigns, advocacy work, and New York Times best-selling series. To join the movement or learn more, visit girlswhocode.com. Follow the organization on social media @GirlsWhoCode.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release

The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye